US Patent Issued to IDORSIA PHARMACEUTICALS on May 6 for "Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives" (Swiss Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,520, issued on May 6, was assigned to IDORSIA PHARMACEUTICALS LTD (Allschwil, Switzerland).

"Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives" was invented by Martin Bolli (Allschwil, Switzerland), John Gatfield (Allschwil, Switzerland), Corinna Grisostomi (Allschwil, Switzerland), Lubos Remen (Allschwil, Switzerland), Christoph Sager (Allschwil, Switzerland) and Cornelia Zumbrunn (Allschwil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of Formula (I)wherein Ar1, Ar2, L, n, and R1 are as described in the description, their preparation, to pharmaceutically acceptable salts the...